 |
| |
Axsome Therapeutics
| 8,15 € | -1,57% | -0,13 € |
17:40:22 Uhr Stuttgart | Mehr Kurse »
WKN: A2AA7B
ISIN: US05464T1043
US-Symbol:
AXSM
Typ: Aktie
- Push
- Intraday
- 5 Tage
- 3 Monate
- 1 Jahr
- Gesamt
Performance Axsome Therapeutics Aktie
| 1 Woche | 1 Monat | 3 Monate | Lfd. Jahr | 1 Jahr | 3 Jahre | |
| Kurs | 9,24 $ | 8,16 $ | 2,82 $ | 2,82 $ | 2,70 $ | 8,39 $ |
| Änderung | +0,97% | +14,34% | +230,85% | +230,85% | +245,56% | +11,20% |
Nachrichten zur Axsome Therapeutics Aktie
| 08.01.19 | Thinking about buying stock in Apple, Axsome Therapeutics, Luxoft, Netflix or QEP Resources? | PR Newswire |
Forum zur Axsome Therapeutics Aktie
Vassago: AXSM 9,95$
05.02.19
AXS-12 Phase II Studie beginnthttps://seekingalpha.com/news/3427477-axsome-therapeutics-begins-mid-stage-study-axsminus-12-narcolepsy
Chalifmann3: hier
30.10.17
https://de.finance.yahoo.com/quote/AXSM/profile?p=AXSM
Axsome Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for the management of central nervous system (CNS) disorders. The company"s product candidates include AXS-05 that ...
Axsome Therapeutics Aktie & Unternehmen
| Branche | Gesundheit/Healthcare |
| Herkunft | USA |
| Website | www.axsome.com |
| Aktienanzahl | 29,8 Mio. (Stand: 13.12.18) |
| Marktkap. | 243,0 Mio. € |
Ähnliche Aktien
| Aleafia Health | 1,61 € | 0,00% | |
| Abbvie | 71,69 € | +0,53% | |
| Fitbit | 5,58 € | -3,46% | |
| Volitionrx | 2,88 $ | 0,00% | |
| Viking Therapeutics | 8,16 € | +1,12% |
Zum Seitenanfang
